FLGT

Fulgent Genetics, Inc.

Health Care · Health Care

$273.25 sample

-0.46 (-0.17%) 1D

Market cap

$870.0B

Price as of

2026-10-05

Latest filing

8-K

Alerts

8

Price$273.25 +17.82% 3M daily closessample

273.71225.35

2026-07-082026-07-302026-08-212026-09-112026-10-05

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 30INSInsider sell: 10% owner
Sep 23INSInsider sell: General Counsel
Sep 15INSInsider buy: Director
Sep 04INSInsider sell: EVP, Operations
Aug 26INSInsider buy: Chief Executive Officer
Aug 17INSInsider buy: 10% owner
Aug 11INSInsider buy: General Counsel
Jul 31INSInsider sell: General Counsel

Sign up to see the real FLGT record →

Company facts

SEC EDGAR registration

Name: Fulgent Genetics, Inc.
Sector: Health Care
Industry: Health Care
Smart-money score: -37sample, -100 to +100
Reporting currency: USD

Who is positioning in FLGT

sample

Insiders: 9 insider transactions over 90 days, net selling, $582.1M
Congress: 5 members traded over 90 days
Institutions · 13F: 11 funds hold $9.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$20.6B +18.5% y/y

Q4 2024Q3 2026

Inventory$12.4B +10.8% y/y

Q4 2024Q3 2026

Accounts receivable$9.2B +9.5% y/y

Q4 2024Q3 2026

Total debt$24.4B +8.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $844.1B +2.7% 3M
Sample peer B: $695.6B +10.2% 3M
Sample peer C: $241.6B -8.1% 3M
Sample peer D: $671.8B +6.1% 3M
Sample peer E: $211.5B -3.8% 3M